tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IOVA Stock Latest News

Iovance Biotherapeutics’ Earnings Call Highlights Growth
Company AnnouncementsIovance Biotherapeutics’ Earnings Call Highlights Growth
3d ago
IOVA
Tesla disbands supercomputer team, Trade Desk Q2 spurs downgrades: Morning Buzz
PremiumThe Fly
Tesla disbands supercomputer team, Trade Desk Q2 spurs downgrades: Morning Buzz
7d ago
LZ
SG
Iovance Biotherapeutics price target lowered to $14 from $18 at Wells Fargo
PremiumThe Fly
Iovance Biotherapeutics price target lowered to $14 from $18 at Wells Fargo
7d ago
IOVA
Iovance Biotherapeutics Reports Strong Revenue Growth in Q2 2025
PremiumCompany Announcements
Iovance Biotherapeutics Reports Strong Revenue Growth in Q2 2025
8d ago
IOVA
Iovance Biotherapeutics: Overcoming Revenue Shortfalls with Strategic Growth Initiatives
PremiumRatings
Iovance Biotherapeutics: Overcoming Revenue Shortfalls with Strategic Growth Initiatives
8d ago
IOVA
Iovance Biotherapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsIovance Biotherapeutics Reports Q2 2025 Financial Results
8d ago
8K
IOVA
Iovance Biotherapeutics reports Q2 EPS (33c), consensus 928c)
Premium
The Fly
Iovance Biotherapeutics reports Q2 EPS (33c), consensus 928c)
8d ago
IOVA
Iovance Biotherapeutics backs FY25 revenue view $250M-$200M, consensus $287.11M
Premium
The Fly
Iovance Biotherapeutics backs FY25 revenue view $250M-$200M, consensus $287.11M
8d ago
IOVA
Iovance Biotherapeutics options imply 23.8% move in share price post-earnings
PremiumThe Fly
Iovance Biotherapeutics options imply 23.8% move in share price post-earnings
8d ago
IOVA
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer
PremiumCompany Announcements
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer
8d ago
IOVA
Unusually active option classes on open July 23rd
PremiumThe Fly
Unusually active option classes on open July 23rd
23d ago
WU
RKT
Iovance Biotherapeutics Gains Competitive Edge as Replimune Faces FDA Setback
PremiumRatings
Iovance Biotherapeutics Gains Competitive Edge as Replimune Faces FDA Setback
24d ago
IOVA
Realty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
PremiumWeekend UpdatesRealty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
28d ago
O
DASH
Iovance Biotherapeutics Appoints New Chief Financial Officer
Premium
Company Announcements
Iovance Biotherapeutics Appoints New Chief Financial Officer
1M ago
8K
IOVA
Iovance Biotherapeutics appoints Roche as CFO
Premium
The Fly
Iovance Biotherapeutics appoints Roche as CFO
1M ago
IOVA
Iovance Biotherapeutics downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
Iovance Biotherapeutics downgraded to Sell from Neutral at Goldman Sachs
1M ago
IOVA
H.C. Wainwright sees ‘impressive’ commercial data for Iovance’s Amtagvi
PremiumThe Fly
H.C. Wainwright sees ‘impressive’ commercial data for Iovance’s Amtagvi
1M ago
IOVA
Iovance Biotherapeutics announces real-world study data on Amtagvi
PremiumThe Fly
Iovance Biotherapeutics announces real-world study data on Amtagvi
1M ago
IOVA
Iovance Biotherapeutics Advances Phase 3 Study in Melanoma Treatment
PremiumCompany Announcements
Iovance Biotherapeutics Advances Phase 3 Study in Melanoma Treatment
1M ago
IOVA
Iovance Biotherapeutics’ Lifileucel-Pembrolizumab Study: A Potential Game-Changer in Melanoma Treatment
PremiumCompany AnnouncementsIovance Biotherapeutics’ Lifileucel-Pembrolizumab Study: A Potential Game-Changer in Melanoma Treatment
1M ago
IOVA
Iovance Biotherapeutics CFO Resignation and Interim Appointment
Premium
Company Announcements
Iovance Biotherapeutics CFO Resignation and Interim Appointment
1M ago
8K
IOVA
Iovance Biotherapeutics Advances in Melanoma Treatment with Lifileucel-Pembrolizumab Study
Premium
Company Announcements
Iovance Biotherapeutics Advances in Melanoma Treatment with Lifileucel-Pembrolizumab Study
1M ago
IOVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >